SCHEMBL30142740

SCHEMBL30142740

COC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.82
KMT2A Q03164 10/20 0.82
NPC1 O15118 8/20 0.82
RAB9A P51151 8/20 0.82
STAT3 P40763 7/20 0.82
MAPT P10636 5/20 0.82
PKM P14618 4/20 0.82
ALDH1A1 P00352 4/20 0.82
LMNA P02545 3/20 0.82
NPSR1 Q6W5P4 3/20 0.82
HTT P42858 2/20 0.82
SMN1; SMN2 Q16637 2/20 0.82
MLNR O43193 1/20 0.82
NR1I2 O75469 1/20 0.82
ABCB11 O95342 1/20 0.82
TP53 P04637 1/20 0.82
ADRB2 P07550 1/20 0.82
CHRM2 P08172 1/20 0.82
ADRB1 P08588 1/20 0.82
CYP3A4 P08684 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29056942 0.94 STAT3 (0.83) MEN1KMT2ANPC1RAB9ASTAT3
SCHEMBL16687504 0.92 MEN1 (0.76) MEN1KMT2ANPC1RAB9ASTAT3
Nitazoxanide SCHEMBL40981 0.90 STAT3 (1.00) MEN1KMT2ANPC1RAB9ASTAT3
Nitazoxanide SCHEMBL29373905 0.90 STAT3 (1.00) MEN1KMT2ANPC1RAB9ASTAT3
Nitazoxanide SCHEMBL5055353 0.90 STAT3 (1.00) MEN1KMT2ANPC1RAB9ASTAT3
SCHEMBL12994083 0.90 NPC1 (0.79) MEN1KMT2ANPC1RAB9ASTAT3
SCHEMBL16687500 0.89 MEN1 (0.76) MEN1KMT2ANPC1RAB9ASTAT3
SCHEMBL8463533 0.89 MEN1 (0.78) MEN1KMT2ANPC1RAB9ASTAT3
SCHEMBL16687499 0.89 MEN1 (0.71) MEN1KMT2ANPC1RAB9ASTAT3
Nitazoxanide SCHEMBL28195534 0.89 STAT3 (0.98) MEN1KMT2ANPC1RAB9ASTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
CN-116472292-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2023-07-21 CN disclosed
EP-4157888-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS Cullgen (Shanghai), Inc. (CN) 2023-04-05 EP disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MEN1 3254/4885KMT2A 1342/4885NPC1 3949/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MEN1 3254/4885KMT2A 1342/4885NPC1 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.